France· FR:64328981
VANIQA 11,5 pour cent, crème
A medicinal product containing chlorhydrate d'éflornithine, registered in France by ALMIRALL (ESPAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'ÉFLORNITHINE
- Manufacturer
- ALMIRALL (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009356700381 tube(s) polyéthylène haute densité (PEHD) de 30 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'éflornithine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomVaniqa 11.5% creamWaymade Healthcare Plc
- CzechiaVANIQAAlmirall, S.A., Barcelona
- SpainVANIQA 11,5 % CREMAAlmirall S.A.
- SwitzerlandIfinwil 192 mg, TablettenNorgine AG
- IrelandVaniqa 11.5%Almirall, S.A.
- NorwayIwilfinUS WorldMeds
- SwedenVaniqa 11,5 % KrämAlmirall S.A.
- BelgiumVaniqa 11.5 %Almirall
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vaniqa
- Liechtenstein · Vaniqa
- Norway · Vaniqa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc445e63-f858-4151-bf00-d5d1f47b24ba GET /v1/drugs/cc445e63-f858-4151-bf00-d5d1f47b24ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64328981",
"date_amm": "2001-03-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/01/173",
"substance": "CHLORHYDRATE D'ÉFLORNITHINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "crème",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'éflornithine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.